Presentation Topic: How far can we go with automation in metagenomic sequencing?
Caroline acquired her PhD in molecular genetics from the Freie Universität Berlin, Germany in 2009, under the supervision of Prof. Hans Lehrach, Director of the Max Planck Institute for Molecular Genetics. Her PhD thesis focused on the molecular mechanism of renal damage in the course of rat hypertension using laser microdissection and Affymetrix gene expression profiling.
Areas of Expertise
Caroline\'s main interest and professional expertise is in the field of next-generation sequencing including Illumina technology. She has more than 20 years of experience in molecular biology including extensive hands-on experience in genomic high-throughput technologies. For the last seven years, she has managed Illumina sequencing platforms, providing outstanding, personalized customer service. Her expertise covers a broad range of Illumina applications such as de novo sequencing, metagenomics, transcriptomics and epigenetic analysis. Caroline\\\\\\\\\\\\\\\'s strengths are innovative solutions and implementing new technological improvements in the NGS workflow, which are critical for improving data quality and reducing sequencing costs.